Dowex Marathon C, H+ form structure
|
Common Name | Dowex Marathon C, H+ form | ||
---|---|---|---|---|
CAS Number | 150604-77-6 | Molecular Weight | N/A | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | N/A | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | DOWEX MARATHON C NA(+)-FORM STRONGLY |
---|---|
Synonym | More Synonyms |
No Any Chemical & Physical Properties |
Polyphosphates and pyrophosphates of hexopyranoses as allosteric effectors of human hemoglobin: synthesis, molecular recognition, and effect on oxygen release.
ChemMedChem 6(1) , 153-68, (2011) Polyphosphorylated and perphosphorylated hexopyranose monosaccharides and disaccharides were synthesized from parent or partially protected carbohydrates as potential allosteric effectors of hemoglobi... |
|
Myo-InositolTrisPyroPhosphate treatment leads to HIF-1α suppression and eradication of early hepatoma tumors in rats.
ChemBioChem. 12(5) , 777-83, (2011) Myo-inositol trispyrophosphate (ITPP), a synthetic allosteric effector of hemoglobin, increases the regulated oxygen-releasing capacity of red blood cells (RBCs), leading to suppression of hypoxia-ind... |
|
Enhanced exercise capacity in mice with severe heart failure treated with an allosteric effector of hemoglobin, myo-inositol trispyrophosphate.
Proc. Natl. Acad. Sci. U. S. A. 106(6) , 1926-9, (2009) A major determinant of maximal exercise capacity is the delivery of oxygen to exercising muscles. myo-Inositol trispyrophosphate (ITPP) is a recently identified membrane-permeant molecule that causes ... |
MFCD00212649 |